Argentinean crackdown on pharma imports causes problems for industry
This article was originally published in SRA
Executive Summary
Protectionist measures aimed at improving Argentina's trade balance are causing problems for both local and multinational pharmaceutical companies operating in the country. Nevertheless, talks between the government and industry are ongoing and the ministry for industry has hinted that import restrictions may be eased in certain circumstances.